{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:58:35Z","timestamp":1774958315793,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196912","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T17:43:10Z","timestamp":1526492590000},"page":"e0196912","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2212-0276","authenticated-orcid":true,"given":"Benjamin Udoka","family":"Nwosu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaa S.","family":"Ayyoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony R.","family":"Villalobos-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura C.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.2337\/dc13-0418","article-title":"Residual beta-Cell function 3\u20136 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents","volume":"36","author":"JS Sorensen","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.26.3.832","article-title":"Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial","volume":"26","author":"MW Steffes","year":"2003","journal-title":"Diabetes Care"},{"key":"ref3","article-title":"Diabetic Microvascular Disease: An Endocrine Society Scientific Statement","author":"EJ Barrett","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1515\/jpem-2017-0019","article-title":"Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of &lt;0.3 units\/kg\/day to the gold standard insulin-dose adjusted hemoglobin A1c of &lt;\/ = 9 for the detection of partial clinical remission","volume":"30","author":"RL Lundberg","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"e0176860","DOI":"10.1371\/journal.pone.0176860","article-title":"A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes","volume":"12","author":"KR Marino","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2796.1999.00426.x","article-title":"Factors predicting clinical remission in adult patients with type 1 diabetes","volume":"245","author":"A Scholin","year":"1999","journal-title":"J Intern Med"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/dme.12097","article-title":"Insulin-dose-adjusted HbA1c-defined partial remission phase in a paediatric population\u2014when is the honeymoon over?","volume":"30","author":"OM Neylon","year":"2013","journal-title":"Diabet Med"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00125-013-3067-x","article-title":"The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells","volume":"57","author":"RA Oram","year":"2014","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"ref9","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.2337\/diabetes.54.suppl_2.S32","article-title":"Natural history of beta-cell function in type 1 diabetes","volume":"54","author":"NA Sherry","year":"2005","journal-title":"Diabetes"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1210\/jc.2008-1209","article-title":"Rate of beta-cell destruction in type 1 diabetes influences the development of diabetic retinopathy: protective effect of residual beta-cell function for more than 10 years","volume":"93","author":"K Nakanishi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jdiacomp.2015.09.002","article-title":"Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes","volume":"29","author":"P Niedzwiecki","year":"2015","journal-title":"J Diabetes Complications"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/dc16-2193","article-title":"Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study","volume":"40","author":"AS Shah","year":"2017","journal-title":"Diabetes Care"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2337\/diacare.27.12.2911","article-title":"Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes","volume":"27","author":"MJ Haller","year":"2004","journal-title":"Diabetes Care"},{"issue":"14","key":"ref14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0002-9149(99)80683-3","article-title":"Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial","volume":"75","year":"1995","journal-title":"Am J Cardiol"},{"issue":"Suppl 2","key":"ref15","first-page":"B35","article-title":"Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis","volume":"22","author":"ML Lawson","year":"1999","journal-title":"Diabetes Care"},{"issue":"21","key":"ref16","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1997.03550210047037","article-title":"Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study","volume":"278","author":"W Bao","year":"1997","journal-title":"JAMA"},{"issue":"23","key":"ref17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"GS Berenson","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/dc16-0430","article-title":"Influence of HbA1c and BMI on Lipid Trajectories in Youths and Young Adults With Type 1 Diabetes","volume":"40","author":"ML Katz","year":"2017","journal-title":"Diabetes Care"},{"issue":"17","key":"ref19","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.290.17.2277","article-title":"Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study","volume":"290","author":"OT Raitakari","year":"2003","journal-title":"JAMA"},{"issue":"Suppl 5","key":"ref20","first-page":"S213","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/cd16-0067","article-title":"Standards of Medical Care in Diabetes-2017 Abridged for Primary Care Providers","volume":"35","year":"2017","journal-title":"Clinical diabetes: a publication of the American Diabetes Association"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"e99646","DOI":"10.1371\/journal.pone.0099646","article-title":"The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus","volume":"9","author":"BU Nwosu","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc08-1987","article-title":"New definition for the partial remission period in children and adolescents with type 1 diabetes","volume":"32","author":"HB Mortensen","year":"2009","journal-title":"Diabetes Care"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/pedi.12208","article-title":"Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes","volume":"15","author":"ML Max Andersen","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"ref25","article-title":"Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria","author":"K Nagl","year":"2016","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"e101583","DOI":"10.1371\/journal.pone.0101583","article-title":"The vitamin d status in inflammatory bowel disease","volume":"9","author":"LE Veit","year":"2014","journal-title":"PLoS One"},{"issue":"246","key":"ref27","first-page":"1","article-title":"CDC Growth Charts for the United States: methods and development","author":"RJ Kuczmarski","year":"2000","journal-title":"Vital Health Stat 11"},{"key":"ref28","article-title":"The non-dietary determinants of vitamin D status in pediatric inflammatory bowel disease","author":"LE Veit","year":"2015","journal-title":"Nutrition"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-543X.2005.00088.x","article-title":"Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT\/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study","volume":"6","author":"WV Tamborlane","year":"2005","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4158\/EP171764.GL","article-title":"AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE\u2014EXECUTIVE SUMMARYComplete Appendix to Guidelines available at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/journals.aace.com\" xlink:type=\"simple\">http:\/\/journals.aace.com<\/ext-link>","volume":"23","author":"PS Jellinger","year":"2017","journal-title":"Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/clinchem\/36.1.15","article-title":"Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints","volume":"36","author":"GR Warnick","year":"1990","journal-title":"Clin Chem"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1399-5448.2000.010204.x","article-title":"Type 1 diabetic children have abnormal lipid profiles during pubertal years","volume":"1","author":"M Polak","year":"2000","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/pedi.12385","article-title":"HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes","volume":"18","author":"B Obermannova","year":"2017","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/jpem-2016-0111","article-title":"The prevalence of dyslipidemia and associated factors in children and adolescents with type 1 diabetes","volume":"30","author":"T Bulut","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1475-2840-11-156","article-title":"Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey","volume":"11","author":"FM Giuffrida","year":"2012","journal-title":"Cardiovascular diabetology"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/15438600490424569","article-title":"C-peptide and retinal microangiopathy in diabetes","volume":"5","author":"S Chakrabarti","year":"2004","journal-title":"Experimental diabesity research"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2009-1756","article-title":"Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function","volume":"95","author":"KJ Nadeau","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1018796","DOI":"10.1155\/2017\/1018796","article-title":"Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects","volume":"2017","author":"FC Cartolano","year":"2017","journal-title":"Journal of diabetes research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T20:11:40Z","timestamp":1661285500000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196912"}},"subtitle":[],"editor":[{"given":"Massimo","family":"Pietropaolo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196912","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]}}}